Señales en vivo de ALMDT.PA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:35):

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally...

Stats
Volumen de hoy	39 928.00
Volumen promedio	50 466.00
Capitalización de mercado	59.12M
EPS	€0 ( 2024-04-25 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.16
ATR14	€0.0260 (0.90%)

Volumen Correlación

Largo: 0.11 (neutral)

Corto: 0.51 (weak)

Signal:(52.222) Neutral

Median Technologies SA Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Median Technologies SA Correlación - Moneda/Commodity

-0.48
( neutral )

-0.66
( moderate negative )

0.00
( neutral )

-0.37
( neutral )

0.37
( neutral )

0.63
( weak )

Median Technologies SA Finanzas

Annual	2023
Ingresos:	€22.20M
Beneficio Bruto:	€22.20M (100.00 %)
EPS:	€0

FY	2023
Ingresos:	€22.20M
Beneficio Bruto:	€22.20M (100.00 %)
EPS:	€0

FY	2022
Ingresos:	€23.67M
Beneficio Bruto:	€24.42M (103.17 %)
EPS:	€-1.280

FY	2021
Ingresos:	€20.55M
Beneficio Bruto:	€20.43M (99.43 %)
EPS:	€-1.250

Financial Reports:

No articles found.

Median Technologies SA

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.